In a survey released by Community Oncology Alliance (COA), the majority of physicians reported concern over proposals to reform the Medicare Part B program
In a survey released by Community Oncology Alliance (COA), the majority of physicians reported concern over proposals to reform the Medicare Part B program. The survey included 100 oncologists/hematologists and 50 rheumatologists. COA commissioned the survey to gain insight into physician perspectives of 2 proposals set forth by the Medicare Payment Advisory Commission and mentioned by President Donald Trump in his blueprint to lower drug prices and out-of-pocket costs.
The survey inquired about opinions on the revamped Competitive Acquisition Program, in which select private vendors would negotiate drug prices with manufacturers, and a proposal to shift prescription drugs currently paid under Medicare Part B into the Medicare Part D program.
Physicians indicated that they are worried the proposed changes would reduce care choices, increase costs and administrative burden, and decrease physician autonomy.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More